Tijana Ignjatovic is Vice President, Access & Pricing at Genesis Research Group, bringing more than 16 years of market access consulting experience. Her expertise spans payer research, pricing, reimbursement, biosimilars, and the development of evidence-based strategic recommendations. Tijana has contributed to more than 100 market access research projects and previously held senior roles in market access consulting and research. She holds a PhD in Biochemistry and Structural Biology from the University of Cambridge and a Postgraduate Certificate in International Health Technology Assessment from the University of Sheffield.
